Skip to content

Study of infection zika virus in pregnancy and infants

International prospective observational cohort study of zika in infants and pregnancy - ZIP study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-73tqdf
Enrollment
Unknown
Registered
2017-07-26
Start date
2016-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Verifie the sequelae of zika virus infection in fetuses and infants born of mothers with had the infection during the pregnancy , particularly the involvement by microcephaly . This study aims to include healthy pregnant in the first trimester of pregnancy and follow them throughout the pregnancy and babies born of these being pregnant that were affected or not by the virus zika

Interventions

There is no intervention in the groups in study. This is a comparative observational study of babies born to pregnant women who had the infection zika virus during pregnancy and pregnant women who did
Other
V03.175.500
E05.318.308.980
E05.295.750
M01.526.485.500
E01.370.225.998.110

Sponsors

Fundação Oswaldo Cruz
Lead Sponsor
National Institutes of Health
Collaborator

Eligibility

Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: PREGNANCY Consent; Older than 15 years; Authorization and consent provided by local law; Pregnancy confirm by measuring beta hCG blood / urine or through fetal heartbeat on ultrasound exam; Proof that the participant is in first trimester of pregnancy (between 4 and 12 weeks) by gestational calculator or fetal ultrasound; NEWBORN All children born to women enrolled in the observational cohort are eligible for the study

Exclusion criteria

Exclusion criteria: PREGNANCY Women who can´t join the proposed protocol program; Pregnant women enrolled in other studies , including other research ZIKV; NEWBORN If the legal representant of the child doesn´t consent to the child to participate to the study; Babies born to mothers who aren´t partipate of the ZIP cohort study

Design outcomes

Primary

MeasureTime frame
Expected to estimate the incidence of congenital malformations and adverse outcomes (including microcephaly, fetuses death, neonatal death, CNS malformations, dropsy and ocular problems) in fetuses/newborn of women who are infected with ZIKV and those who were not infected

Secondary

MeasureTime frame
Malformation in neurodeveloping in the first year of life in babies borned ;;Expected to estimate the seroconversion rate of Zika virus in pregnant women monitored in endemic regions ;Expected to estimate the rate of incidence of long-term clinical sequelae in infected children

Countries

Brazil, Colombia, Guatemala, Nicaragua, Puerto Rico, United States

Contacts

Public ContactMaria Moreira

Fundação Oswaldo Cruz

bebeth@iff.fiocruz.br552125541918

Outcome results

None listed

Source: REBEC (via WHO ICTRP)